Deakin UniversityBrowse

File(s) not publicly available

A randomized phase 2, single-blind study of temozolomide (TMZ) and radiotherapy (RT) combined with nivolumab or placebo (PBO) in newly diagnosed adult patients (pts) with tumor O6-methylguanine DNA methyltransferase (MGMT)-methylated glioblastoma (GBM)—CheckMate-548

journal contribution
posted on 2016-10-01, 00:00 authored by M Weller, G Vlahovic, Mustafa KhasrawMustafa Khasraw, A A Brandes, R Zwirtes, K Tatsuoka, A F Carpentier, D A Reardon, M Bent
A randomized phase 2, single-blind study of temozolomide (TMZ) and radiotherapy (RT) combined with nivolumab or placebo (PBO) in newly diagnosed adult patients (pts) with tumor O6-methylguanine DNA methyltransferase (MGMT)-methylated glioblastoma (GBM)—CheckMate-548

History

Journal

Annals of Oncology

Volume

27

Pagination

vi113 - ?

Publisher DOI

Link to full text

ISSN

0923-7534

eISSN

1569-8041

Publication classification

E3 Extract of paper

Usage metrics

Read the peer-reviewed publication

A randomized phase 2, single-blind study of temozolomide (TMZ) and radiotherapy (RT) combined with nivolumab or placebo (PBO) in newly diagnosed adult patients (pts) with tumor O6-methylguanine DNA methyltransferase (MGMT)-methylated glioblastoma (GBM)—CheckMate-548
Research PublicationsResearch Publications

Categories

Keywords

Science & TechnologyLife Sciences & BiomedicineOncology

Licence

All Rights Reserved

Exports